Design of Remarkably Simple, Yet Potent Urea-Based Inhibitors of Glutamate Carboxypeptidase II (NAALADase)-Reference-Cited by-同舟云学术

Design of Remarkably Simple, Yet Potent Urea-Based Inhibitors of Glutamate Carboxypeptidase II (NAALADase)

Published:2001-01-03 Issue:3 Volume:44 Page:298-301
ISSN:0022-2623
Container-title:Journal of Medicinal Chemistry
language:en
Short-container-title:J. Med. Chem.

Author:

Kozikowski Alan P.¹,Nan Fajun¹,Conti Paola¹,Zhang Jiazhong¹,Ramadan Epolia¹,Bzdega Tomasz¹,Wroblewska Barbara¹,Neale Joseph H.¹,Pshenichkin Sergey¹,Wroblewski Jarda T.¹

Affiliation:

1. Drug Discovery Program, Department of Neurology, and Department of Pharmacology, Georgetown University Medical Center, 3900 Reservoir Road, N.W., Washington, D.C. 20007, and Department of Biology, Georgetown University, Washington, D.C. 20057

Publisher

American Chemical Society (ACS)

Subject

Drug Discovery,Molecular Medicine

Link

https://pubs.acs.org/doi/pdf/10.1021/jm000406m

Reference29 articles.

1. N-acetylaspartylglutamate activates cyclic AMP-coupled metabotropic glutamate receptors in cerebellar astrocytes

2. N-Acetylaspartylglutamate Inhibits Forskolin-Stimulated Cyclic AMP Levels via a Metabotropic Glutamate Receptor in Cultured Cerebellar Granule Cells

Cited by 217 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Zinc‐Binding Oligonucleotide Backbone Modifications for Targeting a DNA‐Processing Metalloenzyme;ChemBioChem;2024-09-05

2. Evaluation of a bimodal, matched pair theranostic agent targeting prostate-specific membrane antigen;Nuclear Medicine and Biology;2024-09

3. “One Method to Label Them All”: A Single Fully Automated Protocol for GMP-Compliant ⁶⁸Ga Radiolabeling of PSMA-11, Transposable to PSMA-I&T and PSMA-617;Current Radiopharmaceuticals;2024-09

4. Clinical Positron Emission Tomography/Computed Tomography;PET Clinics;2024-04

5. Resolute Progress Down a Long and Winding Road Leads to the Promised Land of Prostate-Specific Membrane Antigen–Based Therapies for Prostate Cancer;Journal of Clinical Oncology;2024-03-01